332 related articles for article (PubMed ID: 21158978)
1. Immunotherapy for Alzheimer's disease.
Morgan D
J Intern Med; 2011 Jan; 269(1):54-63. PubMed ID: 21158978
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of A beta plaque clearance following passive A beta immunization.
Morgan D
Neurodegener Dis; 2005; 2(5):261-6. PubMed ID: 16909007
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.
Minami SS; Sidahmed E; Aid S; Shimoji M; Niikura T; Mocchetti I; Rebeck GW; Prendergast JS; Dealwis C; Wetzel R; Bosetti F; Matsuoka Y; Hoe HS; Turner RS
J Neuroinflammation; 2010 Sep; 7():57. PubMed ID: 20920207
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-ß-directed immunotherapy for Alzheimer's disease.
Lannfelt L; Relkin NR; Siemers ER
J Intern Med; 2014 Mar; 275(3):284-95. PubMed ID: 24605809
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta immunotherapy for Alzheimer's disease.
Fu HJ; Liu B; Frost JL; Lemere CA
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):197-206. PubMed ID: 20205640
[TBL] [Abstract][Full Text] [Related]
8. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
Schenk DB; Seubert P; Grundman M; Black R
Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
[TBL] [Abstract][Full Text] [Related]
9. Anti-amyloid-beta immunotherapy in Alzheimer's disease: relevance of transgenic mouse studies to clinical trials.
Wilcock DM; Colton CA
J Alzheimers Dis; 2008 Dec; 15(4):555-69. PubMed ID: 19096156
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
Li Y; Liu Y; Wang Z; Jiang Y
Expert Opin Biol Ther; 2013 Nov; 13(11):1515-22. PubMed ID: 24053611
[TBL] [Abstract][Full Text] [Related]
11. [Perspectives in immunotherapy of Alzheimer's disease].
Rossi G
Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235
[TBL] [Abstract][Full Text] [Related]
12. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
Lemere CA
Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy as treatment for Alzheimer's disease.
Hawkes CA; McLaurin J
Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
[TBL] [Abstract][Full Text] [Related]
14. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
15. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
Cribbs DH
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
[TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability and immunogenicity of an active anti-Aβ
Lacosta AM; Pascual-Lucas M; Pesini P; Casabona D; Pérez-Grijalba V; Marcos-Campos I; Sarasa L; Canudas J; Badi H; Monleón I; San-José I; Munuera J; Rodríguez-Gómez O; Abdelnour C; Lafuente A; Buendía M; Boada M; Tárraga L; Ruiz A; Sarasa M
Alzheimers Res Ther; 2018 Jan; 10(1):12. PubMed ID: 29378651
[TBL] [Abstract][Full Text] [Related]
17. Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's disease.
Morgan D; Gitter BD
Neurobiol Aging; 2004; 25(5):605-8. PubMed ID: 15172737
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.
Menéndez-González M; Pérez-Piñera P; Martínez-Rivera M; Muñiz AL; Vega JA
Curr Pharm Des; 2011; 17(5):508-20. PubMed ID: 21375481
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy for Alzheimer's disease targeting Aβ].
Tabira T
Nihon Rinsho; 2016 Mar; 74(3):423-6. PubMed ID: 27025080
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Alzheimer's disease.
Morgan D
J Alzheimers Dis; 2006; 9(3 Suppl):425-32. PubMed ID: 16914881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
